ERT to Acquire PHT Corporation

February 27, 2015

Applied Clinical Trials

ERT, a leading global solution provider for high- quality patient safety and efficacy endpoint data collection, and PHT Corporation (PHT), the eClinical innovator leading the adoption of patient-driven mobile apps for improved clinical research, announced today that they have signed a definitive agreement under which ERT will acquire PHT.

ERT, a global solutions provider for high-quality patient safety and efficacy endpoint data collection, and PHT Corporation (PHT), an eClinical provider leading the adoption of patient?driven mobile apps, announced today that they have signed a definitive agreement under which ERT will acquire PHT. Financial terms of the transaction were not disclosed. The transaction combines the flexible PHT eCOA platform with the leading clinical trial technology and service offerings of ERT, creating a comprehensive solution for patient endpoint collection and data analytics for global clinical trials.

Read the full release here.